- Generic name
- Topiramate
- Strength
- 25 mg
- Dosage form
- Tablet
- Manufactured by
- Square Pharmaceuticals PLC.
Piramed Tablet
About Piramed 25 mg Tablet
Piramed 25 mg Tablet is an anti-epileptic medicine. It is used to treat certain types of seizures in adults and children. The active ingredient is topiramate. Doctors prescribe it as part of a broader treatment plan.
There are 9 brands of Topiramate listed in Bangladesh. The lowest listed price is Topmate 100 mg Tablet at ৳ 1 per unit.
What is Piramed 25 mg Tablet?
Piramed 25 mg Tablet is a medicine that helps control seizures. It belongs to a group of drugs called anti-epileptic medicines. Seizures happen when there is a sudden, abnormal burst of electrical activity in the brain. Topiramate works in ways that are not fully understood, but it is thought to affect certain nerve signals in the brain to reduce seizure activity. Doctors prescribe Piramed as either the only anti-epileptic medicine or alongside other medicines, depending on the person's condition. It is available as a 25 mg tablet and should only be used under a doctor's supervision.
Uses of Piramed
Piramed 25 mg Tablet is used for epilepsy. It can be prescribed on its own for adults and children with newly diagnosed epilepsy who have certain types of seizures, such as generalised tonic-clonic seizures or partial seizures. It can also be used together with other anti-epileptic medicines when those medicines alone do not control seizures well enough. Your doctor will decide whether Piramed is suitable for you and how it fits into your overall treatment.
How to use Piramed
Always take Piramed 25 mg Tablet exactly as your doctor tells you. Your doctor will decide the right dose and how often you should take it, and will also decide how long you need to keep taking it. Swallow the tablet with water, with or without food, unless your doctor advises otherwise. Do not change the dose or stop taking this medicine on your own, because stopping suddenly can cause problems. If you miss a dose, ask your doctor or pharmacist what to do.
Side effects of Piramed
Like all medicines, Piramed 25 mg Tablet can cause side effects. Common ones include nausea, stomach pain, indigestion, diarrhoea, dry mouth, taste changes, weight loss, loss of appetite, tingling or numbness, headache, tiredness, dizziness, speech problems, drowsiness, trouble sleeping, and problems with memory or concentration. Some people may feel anxious or depressed, or have vision problems. Serious side effects are rare but possible. Tell your doctor if you notice any side effect, especially if it bothers you or does not go away.
Safety and precautions
Before taking Piramed 25 mg Tablet, tell your doctor about all your health conditions and any medicines you take. This medicine can make you drowsy or cause blurred vision. If you are affected, do not drive, use machines, or do anything that could be dangerous. Alcohol and other medicines that make you sleepy should be used with caution. Do not stop taking this medicine suddenly; your doctor will tell you how to stop it safely. Piramed should not be used during pregnancy or breastfeeding unless your doctor decides it is necessary. Always ask your doctor first if you are pregnant, planning a pregnancy, or breastfeeding.
Frequently asked questions
What is Piramed 25 mg Tablet used for and what kind of medicine is it?
Piramed 25 mg Tablet is an anti-epileptic medicine. It is used to treat certain types of seizures in adults and children. It may be prescribed alone or with other anti-epileptic medicines. Your doctor will decide if it is right for you.
How should I take Piramed 25 mg Tablet?
Take Piramed 25 mg Tablet exactly as your doctor prescribes. Your doctor will decide the dose, how often to take it, and how long to continue. Swallow the tablet with water. Do not change the dose or stop the medicine on your own without talking to your doctor first.
How should I store Piramed 25 mg Tablet?
Store Piramed 25 mg Tablet below 30°C, away from light and moisture. Keep it out of the reach of children. Do not use it after the expiry date printed on the pack. If you have any questions about storage, ask your pharmacist.
Can I stop taking Piramed 25 mg Tablet suddenly?
No, do not stop taking Piramed 25 mg Tablet suddenly. Stopping an anti-epileptic medicine abruptly can cause seizures or make them worse. Your doctor will tell you how to reduce the dose safely if you need to stop. Always follow your doctor's instructions.
Also available as
Indications
Migraine: Topiramate is indicated in adults for the prophylaxis of migraine headache. Prophylactic treatment of migraine may be considered in situations such as: adults experiencing three or more migraine attacks per month; frequent migraine attacks that significantly interfere with the patient's daily routine. Continuing therapy should be reviewed every six months.
Pharmacology
The exact mechanisms by which topiramate exerts pharmacological actions on seizures and migraines are currently not fully characterized. Several properties of this drug, however, are likely to contribute to its therapeutic effects. Topiramate has been observed to exert actions on voltage-dependent sodium channels, GABA receptors, and glutamate receptors.
Topiramate stimulates GABA-A receptor activity at brain non-benzodiazepine receptor sites and reduces glutamate activity at both AMPA and kainate receptors. Normally, GABA-A receptors are inhibitory and glutaminergic receptors are stimulatory for neuronal activity. By increasing GABA activity and inhibiting glutamate activity, topiramate blocks neuronal excitability, preventing seizures and migraines. Additionally, it blocks the voltage-dependent sodium channels, further blocking seizure activity. Topiramate has been shown to inhibit various carbonic anhydrase isozymes, but the clinical significance of this is unknown at this time.
Dosage & Administration
- Adults and children over 16 years: Titration should begin at 25 mg nightly for 1 week. The dosage should then be increased at 1- or 2-week intervals by increments of 25 or 59 mg/day, administered in two divided doses. The recommended initial target dose for topiramate monotherapy in adults with newly diagnosed epilepsy is 100 mg/day and the maximum recommended daily dose is 400 mg.
- Children aged 6-16 years: Treatment of children aged 6 years and above should begin at 0.5 to 1 mg/kg nightly for the first week. The dosage should then be increased at 1- or 2-week intervals by increments of 0.5 to 1 mg/kg/day, administered in two divided doses. The recommended initial target dose range for topiramate monotherapy in children with newly diagnosed epilepsy aged 6 years and above is 3 to 6 mg/kg/day. Higher doses have been tolerated and rarely doses up to 16 mg/kg/day have been given.
- Adults and children over 16 years: The minimal effective dose as adjunctive therapy is 200 mg per day. The usual total daily dose is 200 mg to 400 mg in two divided doses. Some patients may require doses up to 800 mg per day, which is the maximum recommended dose.
- Children aged 2-16 years: The recommended total daily dose of Topiramate as adjunctive therapy is approximately 5 to 9 mg/kg/day in two divided doses. Titration should begin at 25 mg nightly for the first week. The dosage should then be increased at 1- or 2-week intervals by increments of 1 to 3 mg/kg/day (administered in two divided doses), to achieve optimal clinical response. Dose titration should be guided by clinical outcome. Daily doses up to 30 mg/kg/day have been studied and were generally well tolerated.
- Adults and children over 16 years: Titration should begin at 25 mg nightly for 1-week. The dosage should then be increased in increments of 25 mg/day administered at 1-week intervals. The recommended total daily dose of topiramate as treatment for the prophylaxis of migraine headache is 100 mg/day administered in two divided doses. Some patients may experience a benefit at a total daily dose of 50 mg/day.
- Children: Topiramate in migraine prophylaxis has not been studied in children under 16 years.
Interaction
CNS Depressants: Topiramate should be used with caution if used in combination with alcohol and other CNS depressants.
Oral Contraceptives: In an interaction study with a combined oral contraceptive, Topiramate increased plasma clearance of the oestrogenic component significantly. Consequently, and bearing in mind the potential risk of teratogenicity, patients should receive a preparation containing not less than 50 μg of oestrogen or use some alternative non-hormonal method of contraception. Patients taking oral contraceptives should be asked to report any change in their bleeding patterns.
Lithium: In patients with bipolar disorder, the pharmacokinetics of lithium were unaffected during treatment with Topiramate at doses of 200 mg/day; however, there was an observed increase in systemic exposure (26% for AUC) following Topiramate doses of up to 600 mg/day. Lithium levels should be monitored when co-administered with Topiramate.
Hydrochlorothiazide (HCTZ): The steady-state pharmacokinetics of HCTZ were not significantly influenced by the concomitant administration of Topiramate. Clinical laboratory results indicated decreases in serum potassium after Topiramate or HCTZ administration, which were greater when HCTZ and Topiramate were administered in combination.
Metformin: Topiramate did not affect metformin tmax. The clinical significance of the effect of topiramate on metformin pharmacokinetics is unclear. Oral plasma clearance of topiramate appears to be reduced when administered with metformin. The clinical significance of the effect of metformin on topiramate pharmacokinetics is unclear. When Topiramate is added or withdrawn in patients on metformin therapy, careful attention should be given to the routine monitoring for adequate control of their diabetic disease state.
Pioglitazone: When Topiramate is added to pioglitazone therapy or pioglitazone is added to Topiramate therapy, careful attention should be given to the routine monitoring of patients for adequate control of their diabetic disease state.
Glibenclamide: The steady-state pharmacokinetics of Topiramate were unaffected by concomitant administration of glibenclamide. When Topiramate is added to glibenclamide therapy or glibenclamide is added to Topiramate therapy, careful attention should be given to the routine monitoring of patients for adequate control of their diabetic disease state.
Others: Topiramate, when used concomitantly with other agents predisposing to nephrolithiasis, may increase the risk of nephrolithiasis. While using Topiramate, agents like these should be avoided since they may create a physiological environment that increases the risk of renal stone formation. The interaction with benzodiazepines has not been studied.
Valproic Acid: Concomitant administration of Topiramate and valproic acid has been associated with hyperammonemia with or without encephalopathy in patients who have tolerated either drug alone. An association of hyperammonemia with Topiramate monotherapy or concomitant treatment with other anti epileptics has not been established.
Contraindications
Side Effects
Pregnancy & Lactation
Precautions & Warnings
Overdose Effects
Storage Conditions
Alternative brands of Topiramate
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.